Pharma Pricing & Market Access Outlook Europe 2009

Quick links

conference details

Conference:

Pre-conference workshop

28 April 9am - 5pm

Day 1

29 April 8.30am - 5:30pm

Day 2

30 April 8.30am - 5:30pm

Post-conference workshop

1 May 9am - 5pm

*New pre-conference workshop venue: Hyatt regency London – The Churchill. > More details

Main venue: Radisson SAS Portman Hotel, London, United Kingdom

› Email a colleague
› Add this to my calendar

our speakers

Speaker photo

Dr Carole Longson

Health Technology Evaluation Director

NICE, UK

Speaker photo
Dr Martin van der Graaf

Secretary Reimbursement Committee

CVZ, Netherlands

Dr Brien Benoit

Chairman

Patented Medicine Prices Review Board

Speaker photo
Professor Silvio Garattini

Founder

Mario Negri Institute, Italy

Plus representation from:

HAS, BlueCross BlueShield, GBA, Johnson & Johnson, Serono, Baxter.

conference:

new workshop venue speaker faq delegate faq

The 3rd annual conference will be even bigger!

This is a unique opportunity to hear from health agencies on the latest policy developments impacting on pharma pricing & reimbursement.

Key issues to be addressed at the 2009 summit include:

• Conclusions of the EU commission High Level Pharma Forum
• Pricing and market access in the major international markets
• The future of risk sharing agreements
• More effective use of pharmacoeconomic data in pricing and reimbursement applications

The world’s largest pharmaceutical pricing event is open for business

The 3rd annual Pharma Pricing and Market Access Outlook, addresses the critical policy issues in developing the optimum pricing strategy for pharmaceutical products.

The event, now established as the largest international pricing and reimbursement event, attracted close to 200 participants in 2008.

The most important factor dictating a products profitability is pricing policy. The path to getting the right price and reimbursement status involves a thorough grasp of the clinical benefits of your product, an up-to-date handle on pricing methodologies and a comprehensive knowledge of the HTA practice in the markets you are working in.

The last 12 months have seen a raft of health policy reform impacting pharmaceutical pricing. The reform of the PPRS and other pricing systems continues as does the innovative new pricing and risk sharing models between industry and payers.

Keeping abreast of these changes and developing a strategy that meets the new challenges will be of paramount importance for manufacturers world wide.

» Reserve your seat now

in association with

sponsors & exhibitors

› See the full sponsors list

sponsorship opportunities

Do you want to do business with senior decision makers from the leading pharma, biotech and health agencies from the pharma pricing industry?

Pharma Pricing & Market Access Outlook is where you will meet your target market.

Target your market!
For details contact
James Hopkins on +44 (0) 207 608 7038

Reserve a stand

Reserve an exhibition stand at Pharma Pricing & Market Access Outlook 2009 - book early to ensure optimum stand placement!

Reserve a stand

For details contact
James Hopkins on +44 (0) 207 608 7038

› Exhibitor FAQ's